{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05940324",
            "orgStudyIdInfo": {
                "id": "70954"
            },
            "secondaryIdInfos": [
                {
                    "id": "1R01MH133553-01",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1R01MH133553-01"
                }
            ],
            "organization": {
                "fullName": "Stanford University",
                "class": "OTHER"
            },
            "briefTitle": "Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)",
            "officialTitle": "Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)",
            "acronym": "MKET2",
            "therapeuticArea": [
                "Other"
            ],
            "study": "examining-mu-opioid-mechanisms-of-ketamine-s-rapid-effects-in-ocd"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-07-03",
            "studyFirstSubmitQcDate": "2023-07-03",
            "studyFirstPostDateStruct": {
                "date": "2023-07-11",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-13",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Carolyn Rodriguez",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "Stanford University"
            },
            "leadSponsor": {
                "name": "Stanford University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute of Mental Health (NIMH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.",
            "detailedDescription": "The proposed mechanistic trial would be the first to probe the role of ketamine's opioid properties in modulating fronto-striatal circuitry and bringing about reduction of OCD symptoms."
        },
        "conditionsModule": {
            "conditions": [
                "Obsessive-Compulsive Disorder"
            ],
            "keywords": [
                "OCD",
                "Ketamine",
                "Naltrexone",
                "MRI",
                "Brain Imaging",
                "OCD symptoms",
                "Obsessive-Compulsive Disorder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Participants will be randomized with a 1:1 allocation to either IV ketamine + oral placebo or IV ketamine + oral opioid antagonist naltrexone",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 150,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Ketamine + Naltrexone",
                    "type": "EXPERIMENTAL",
                    "description": "OCD patients in this arm will receive 0.5mg/kg of ketamine - one single infusion. fMRI will be acquired before, during, and after infusion.\n\nOral naltrexone 50 mg will be administered before the infusion.",
                    "interventionNames": [
                        "Drug: Ketamine",
                        "Drug: Naltrexone Pill"
                    ]
                },
                {
                    "label": "Ketamine + Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "OCD patients in this arm will receive 0.5mg/kg of ketamine - one single infusion. fMRI will be acquired before, during, and after infusion.\n\nAn oral inactive placebo will be administered before the infusion.",
                    "interventionNames": [
                        "Drug: Ketamine",
                        "Other: Placebo pill"
                    ]
                },
                {
                    "label": "Healthy Volunteers",
                    "type": "NO_INTERVENTION",
                    "description": "Healthy volunteers will have one fMRI scan visit."
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ketamine",
                    "description": "Ketamine is an FDA-approved dissociative anesthetic.",
                    "armGroupLabels": [
                        "Ketamine + Naltrexone",
                        "Ketamine + Placebo"
                    ],
                    "otherNames": [
                        "Ketamine Hydrochloride",
                        "Ketalar"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Naltrexone Pill",
                    "description": "Naltrexone is an oral opioid antagonist approved by the Food and Drug Administration (FDA) to treat both alcohol use disorder (AUD) and opioid use disorder (OUD)",
                    "armGroupLabels": [
                        "Ketamine + Naltrexone"
                    ],
                    "otherNames": [
                        "Naltrexone"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo pill",
                    "description": "An oral inactive placebo pill will be administered to preserve the blinded nature of the study.",
                    "armGroupLabels": [
                        "Ketamine + Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)",
                    "description": "Change in OCD severity is measured by the YBOCS (Yale Brown Obsessive-Compulsive Scale), a gold standard measure of obsessions and compulsions. For the YBOCS the minimum units are 0 and Maximum units on the total scale are 40. The higher the number on the YBOCS, the more severe the symptoms. Response is defined as at least a 35% reduction on the YBOCS.",
                    "timeFrame": "Baseline (Visit 2) to Post Infusion fMRI scan (Visit 4; Day 1), up to 1 week"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Eligibility Criteria for Participants with OCD:\n\nInclusion Criteria:\n\n* Ages 18-65\n* Meet the criteria for OCD diagnosis\n* Failed at least 1 prior trial of standard first-line OCD treatment\n* Agree to the following lifestyle modifications: comply with requirements for fasting prior to the Experimental Session, not enroll in any other interventional clinical trials during the duration of the study, and commit to medication study procedures.\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* prior naltrexone or ketamine use/exposure\n* Any current or past medical/psychiatric condition that makes participation unsafe in the opinion of the investigator or study physician\n* Pregnant or nursing, or able to become pregnant and are not practicing an effective means of birth control\n* the presence of metal in the body that is contraindicated for MRI scans\n\nEligibility Criteria for Healthy Volunteers:\n\nInclusion Criteria:\n\n* Ages 18-65\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* current or past use of psychotropic medication\n* pregnant or nursing females\n* the presence of metal in the body that is contraindicated for MRI scans",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Pavithra Mukunda, MS",
                    "role": "CONTACT",
                    "phone": "6504972578",
                    "email": "ocdresearch@stanford.edu"
                },
                {
                    "name": "Carolyn I Rodriguez, MD, PhD",
                    "role": "CONTACT",
                    "phone": "(650) 723-6158",
                    "email": "ocdresearch@stanford.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Department of Psychiatry & Behavioral Sciences",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "OCD Research",
                            "role": "CONTACT",
                            "phone": "650-723-4095"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003193",
                    "term": "Compulsive Personality Disorder"
                },
                {
                    "id": "D000009771",
                    "term": "Obsessive-Compulsive Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010554",
                    "term": "Personality Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000001008",
                    "term": "Anxiety Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12706",
                    "name": "Obsessive-Compulsive Disorder",
                    "asFound": "Obsessive-Compulsive Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6419",
                    "name": "Compulsive Personality Disorder",
                    "asFound": "Compulsive Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13462",
                    "name": "Personality Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4324",
                    "name": "Anxiety Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009271",
                    "term": "Naltrexone"
                },
                {
                    "id": "D000007649",
                    "term": "Ketamine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000778",
                    "term": "Anesthetics, Dissociative"
                },
                {
                    "id": "D000018686",
                    "term": "Anesthetics, Intravenous"
                },
                {
                    "id": "D000018681",
                    "term": "Anesthetics, General"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000018691",
                    "term": "Excitatory Amino Acid Antagonists"
                },
                {
                    "id": "D000018683",
                    "term": "Excitatory Amino Acid Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000427",
                    "term": "Alcohol Deterrents"
                },
                {
                    "id": "D000009292",
                    "term": "Narcotic Antagonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                },
                {
                    "id": "M10674",
                    "name": "Ketamine",
                    "asFound": "Nerve",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3777",
                    "name": "Ethanol",
                    "relevance": "LOW"
                },
                {
                    "id": "M12222",
                    "name": "Naltrexone",
                    "asFound": "Closure",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4108",
                    "name": "Anesthetics, Dissociative",
                    "relevance": "LOW"
                },
                {
                    "id": "M12243",
                    "name": "Narcotic Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20766",
                    "name": "Anesthetics, Intravenous",
                    "relevance": "LOW"
                },
                {
                    "id": "M20761",
                    "name": "Anesthetics, General",
                    "relevance": "LOW"
                },
                {
                    "id": "M20771",
                    "name": "Excitatory Amino Acid Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M12245",
                    "name": "Narcotics",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "AlcDet",
                    "name": "Alcohol Deterrents"
                },
                {
                    "abbrev": "NarcAntag",
                    "name": "Narcotic Antagonists"
                }
            ]
        }
    },
    "hasResults": false
}